MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Should Investors Expect from DexCom's Upcoming Q1 Earnings

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Should Investors Expect from nCino's Upcoming Earnings

2 months ago

What Should Investors Expect from FactSet's Upcoming Earnings

2 months ago

What Should Investors Expect from Archer Aviation's Upcoming Earnings

3 months ago

What Should Investors Expect from Palomar's Q1 2026 Earnings

1 months ago

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

DexCom and Insulet present diverging growth profiles for 2026, with DexCom leveraging steady global profitability while Insulet prioritizes rapid revenue expansion through a specialized product portfo...

DXCM

Stock News•1 months ago

Tandem Diabetes Care, Inc. (TNDM) Q1 2026 Earnings Call Transcript

Tandem Diabetes Care (TNDM) released its Q1 2026 earnings transcript, providing updated financial performance metrics and operational guidance. Investors are evaluating the company's current market po...

TNDM

Stock News•1 months ago

Dexcom to Host Investor Day on May 14, 2026

Dexcom (NASDAQ: DXCM) will host an Investor Day on May 14, 2026, to outline its long-term financial outlook and business strategy. Management will present updates on market opportunities and innovatio...

DXCM

Stock News•1 months ago

Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?

DexCom's Q1 revenue growth may accelerate due to strong G7 uptake and sustained CGM demand. However, potential pricing mix headwinds and increased operating investments could pressure margins, creatin...

DXCM